We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Baxter Healthcare

Develops, manufactures and markets medical products for treatment of hemophilia, immune disorders, infectious disease... read more Featured Products: More products

Download Mobile App




Baxter to Expand Hemodialysis Manufacturing Capacity

By HospiMedica International staff writers
Posted on 31 Aug 2014
Baxter International (Baxter, Deerfield, IL, USA) is planning expand its US manufacturing facility to help address the growing global demand for dialyzers, a critical component in hemodialysis therapy (HD).

Baxter will invest nearly USD 300 million in the Opelika (AL, USA) manufacturing site, adding 21,300 m2 of space and several production lines to accelerate the growth of the dialyzer business unit, which also operates a manufacturing facility in Halle (Germany). More...
The expansion follows the September 2013 purchase of dialysis company Gambro (Stockholm, Sweden) for about USD 3.9 billion, turning the dialysis products business into Baxter’s largest and fastest growing franchise. During the second quarter of 2014, Baxter generated revenues of USD one billion in dialysis product revenues, an increase of 60% over the previous year.

The company, which currently employs about 170 people at the US facility, anticipates it will begin the hiring process of an additional 200 workers in 2016 to support the expansion, which is when the first commercial production on the new lines is slated to begin. The expansion will also assist Baxter in its strategic process of spinning out its therapeutics business into a separate company, and expects to make executive appointments in the fall of 2014. It also plans an investor meeting during the second quarter of 2015 to help outline the two companies.

“Baxter's expansion in Opelika will provide increased production of dialyzers, which are a critical component to the delivery of hemodialysis, a life-sustaining therapy for patients with end-stage renal disease,” said Robert L. Parkinson, Jr., chairman and CEO of Baxter. “In addition to supporting a greater number of patients having access to therapy, the expansion is an investment in the communities where our employees live and work. The collaboration with Governor Robert Bentley, Mayor Gary Fuller and the many other local officials was a key component of our expansion plan.”

There are nearly two million patients worldwide with end-stage renal disease (ESRD) receiving HD therapy, a process by which waste and excess fluids are removed from the body by processing blood through a dialyzer; the filtered blood is then returned to the body. A growing population with diabetes, blood pressure issues, and other key causes of kidney disease, means the incidence rate of ESRD and the need for dialysis is also growing by an estimated 6%–7% annually around the world.

Related Links:

Baxter International
Gambro



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.